100 related articles for article (PubMed ID: 24492027)
1. [Usefulness of measuring serum procalcitonin levels by immunochromatographic assay in febrile neutropenia].
Hatanaka S; Ichihara H; Aoyama Y; Koh S; Yamamura R; Kumura T; Kosaka S; Inaba A; Ohta K; Mugitani A
Rinsho Ketsueki; 2014 Jan; 55(1):105-9. PubMed ID: 24492027
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.
Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M
Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889
[TBL] [Abstract][Full Text] [Related]
3. [Procalcitonin as a predictor of bacteremia in pediatric patients with malignancies and febrile neutropenia].
Aliyev DA; Vezirova ZSh; Geyusheva TF
Klin Khir; 2015 Feb; (2):70-2. PubMed ID: 25985703
[TBL] [Abstract][Full Text] [Related]
4. Development of a fluorescent immnunochromatographic assay for the procalcitonin detection of clinical patients in China.
Wang H; Wang H; Chen S; Dzakah EE; Kang K; Wang J; Wang J
Clin Chim Acta; 2015 Apr; 444():37-42. PubMed ID: 25659293
[TBL] [Abstract][Full Text] [Related]
5. Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia.
Ahn S; Lee YS; Lim KS; Lee JL
Support Care Cancer; 2013 Aug; 21(8):2303-8. PubMed ID: 23519568
[TBL] [Abstract][Full Text] [Related]
6. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
[TBL] [Abstract][Full Text] [Related]
7. Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients.
Bruno B; Busca A; Vallero S; Raviolo S; Mordini N; Nassi L; Cignetti A; Audisio E; Festuccia M; Corsetti A; Depaoli L; Faraci M; Micalizzi C; Corcione S; Berger M; Saglio F; Caropreso P; Mengozzi G; Squadrone V; De Rosa FG; Giaccone L
Expert Rev Hematol; 2017 Jun; 10(6):543-550. PubMed ID: 28471695
[TBL] [Abstract][Full Text] [Related]
8. Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia.
Liu X; Wang DF; Fang Y; Ye WF; Liu S; Lou N
Leuk Lymphoma; 2015 Jan; 56(1):85-91. PubMed ID: 24707944
[TBL] [Abstract][Full Text] [Related]
9. Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.
Wu CW; Wu JY; Chen CK; Huang SL; Hsu SC; Lee MT; Chang SS; Lee CC
Support Care Cancer; 2015 Oct; 23(10):2863-72. PubMed ID: 25701436
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of bacterial infection using procalcitonin].
Takajo I; Okayama A
Rinsho Byori; 2010 May; 58(5):517-22. PubMed ID: 20560461
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of measurement method of a bacterial sepsis marker, procalcitonin].
Adachi S; Nakao K
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2010; 21(2):107-9. PubMed ID: 22096868
[TBL] [Abstract][Full Text] [Related]
12. An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer.
Haeusler GM; Carlesse F; Phillips RS
Pediatr Infect Dis J; 2013 Oct; 32(10):e390-6. PubMed ID: 23673421
[TBL] [Abstract][Full Text] [Related]
13. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.
Lima SS; Nobre V; de Castro Romanelli RM; Clemente WT; da Silva Bittencourt HN; Melo AC; Salomão LC; Serufo JC
Ann Hematol; 2016 Jun; 95(7):1169-76. PubMed ID: 27118539
[TBL] [Abstract][Full Text] [Related]
15. Measurements of procalcitonin facilitate targeting of endotoxin adsorption treatment in febrile neutropenic patients suffering from shock.
Hara M; Tsuchiya K; Nitta K; Ando M
Clin Nephrol; 2014 Jan; 81(1):67-70. PubMed ID: 22909782
[TBL] [Abstract][Full Text] [Related]
16. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
17. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
[TBL] [Abstract][Full Text] [Related]
19. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
